264 related articles for article (PubMed ID: 25586688)
1. Intra-amniotic rAAV-mediated microdystrophin gene transfer improves canine X-linked muscular dystrophy and may induce immune tolerance.
Hayashita-Kinoh H; Yugeta N; Okada H; Nitahara-Kasahara Y; Chiyo T; Okada T; Takeda S
Mol Ther; 2015 Apr; 23(4):627-37. PubMed ID: 25586688
[TBL] [Abstract][Full Text] [Related]
2. Improved transduction of canine X-linked muscular dystrophy with rAAV9-microdystrophin via multipotent MSC pretreatment.
Hayashita-Kinoh H; Guillermo PH; Nitahara-Kasahara Y; Kuraoka M; Okada H; Chiyo T; Takeda S; Okada T
Mol Ther Methods Clin Dev; 2021 Mar; 20():133-141. PubMed ID: 33426145
[TBL] [Abstract][Full Text] [Related]
3. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
Le Guiner C; Servais L; Montus M; Larcher T; Fraysse B; Moullec S; Allais M; François V; Dutilleul M; Malerba A; Koo T; Thibaut JL; Matot B; Devaux M; Le Duff J; Deschamps JY; Barthelemy I; Blot S; Testault I; Wahbi K; Ederhy S; Martin S; Veron P; Georger C; Athanasopoulos T; Masurier C; Mingozzi F; Carlier P; Gjata B; Hogrel JY; Adjali O; Mavilio F; Voit T; Moullier P; Dickson G
Nat Commun; 2017 Jul; 8():16105. PubMed ID: 28742067
[TBL] [Abstract][Full Text] [Related]
4. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
[TBL] [Abstract][Full Text] [Related]
5. Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog.
Koo T; Okada T; Athanasopoulos T; Foster H; Takeda S; Dickson G
J Gene Med; 2011 Sep; 13(9):497-506. PubMed ID: 22144143
[TBL] [Abstract][Full Text] [Related]
6. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.
Gregorevic P; Allen JM; Minami E; Blankinship MJ; Haraguchi M; Meuse L; Finn E; Adams ME; Froehner SC; Murry CE; Chamberlain JS
Nat Med; 2006 Jul; 12(7):787-9. PubMed ID: 16819550
[TBL] [Abstract][Full Text] [Related]
7. Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer.
Foster H; Sharp PS; Athanasopoulos T; Trollet C; Graham IR; Foster K; Wells DJ; Dickson G
Mol Ther; 2008 Nov; 16(11):1825-32. PubMed ID: 18766174
[TBL] [Abstract][Full Text] [Related]
8. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
Koo T; Popplewell L; Athanasopoulos T; Dickson G
Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
[TBL] [Abstract][Full Text] [Related]
9. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression.
Wang Z; Kuhr CS; Allen JM; Blankinship M; Gregorevic P; Chamberlain JS; Tapscott SJ; Storb R
Mol Ther; 2007 Jun; 15(6):1160-6. PubMed ID: 17426713
[TBL] [Abstract][Full Text] [Related]
10. Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy.
Shin JH; Pan X; Hakim CH; Yang HT; Yue Y; Zhang K; Terjung RL; Duan D
Mol Ther; 2013 Apr; 21(4):750-7. PubMed ID: 23319056
[TBL] [Abstract][Full Text] [Related]
11. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S
Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500
[TBL] [Abstract][Full Text] [Related]
12. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
[TBL] [Abstract][Full Text] [Related]
13. C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice.
Yue Y; Liu M; Duan D
Mol Ther; 2006 Jul; 14(1):79-87. PubMed ID: 16563874
[TBL] [Abstract][Full Text] [Related]
14. [Current status and perspective of gene therapy on dystrophic animal model].
Takeda S
Rinsho Shinkeigaku; 2004 Nov; 44(11):911-3. PubMed ID: 15651329
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice.
Bostick B; Yue Y; Lai Y; Long C; Li D; Duan D
Hum Gene Ther; 2008 Aug; 19(8):851-6. PubMed ID: 18666839
[TBL] [Abstract][Full Text] [Related]
18. Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart.
Yue Y; Li Z; Harper SQ; Davisson RL; Chamberlain JS; Duan D
Circulation; 2003 Sep; 108(13):1626-32. PubMed ID: 12952841
[TBL] [Abstract][Full Text] [Related]
19. Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy.
Birch SM; Lawlor MW; Conlon TJ; Guo LJ; Crudele JM; Hawkins EC; Nghiem PP; Ahn M; Meng H; Beatka MJ; Fickau BA; Prieto JC; Styner MA; Struharik MJ; Shanks C; Brown KJ; Golebiowski D; Bettis AK; Balog-Alvarez CJ; Clement N; Coleman KE; Corti M; Pan X; Hauschka SD; Gonzalez JP; Morris CA; Schneider JS; Duan D; Chamberlain JS; Byrne BJ; Kornegay JN
Sci Transl Med; 2023 Jan; 15(677):eabo1815. PubMed ID: 36599002
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Immunomodulatory Treatments on Anti-Dystrophin Immune Response After AAV Gene Therapy in Dystrophin Deficient mdx Mice.
Li N; Parkes JE; Spathis R; Morales M; Mcdonald J; Kendra RM; Ott EM; Brown KJ; Lawlor MW; Nagaraju K
J Neuromuscul Dis; 2021; 8(s2):S325-S340. PubMed ID: 34569971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]